Susquehanna International Group, LLP Tempest Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

  • $568 Billion
  • Q1 2025

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2025

May 14, 2025
SELL
$0.77 - $9.59 $23,331 - $290,577
-30,300 Reduced 35.94%
54,000 $517,000
Q4 2024

Feb 14, 2025
BUY
$0.7 - $1.45 $20,720 - $42,920
29,600 Added 54.11%
84,300 $70,000
Q3 2024

Nov 14, 2024
BUY
$0.96 - $2.23 $52,512 - $121,981
54,700 New
54,700 $76,000
Q4 2023

Feb 14, 2024
BUY
$0.23 - $9.77 $6,670 - $283,330
29,000 New
29,000 $127,000

Others Institutions Holding TPST

# of Institutions
28
Shares Held
2.04M
Call Options Held
42.8K
Put Options Held
72.9K
View Full List

About Tempest Therapeutics, Inc.

TPST Quotes by TradingView
  • Ticker TPST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,418,900
  • Market Cap $70.6M
  • Description
  • Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...
More about TPST
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email